• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA panel to mull cardiac heater-coolers over infection risk

FDA panel to mull cardiac heater-coolers over infection risk

April 15, 2016 By Fink Densford

FDA

The FDA said today it will hold a public advisory committee meeting of its Circulatory System Devices Panel to discuss bacterial infections associated with the use of heater-cooler devices during cardiac surgical procedures.

The federal watchdog said it will seek expert scientific and clinical opinions on the contamination of heater-coolers, as well as patient infections and mitigation strategies to prevent future infections.

The agency said it will provide recommendations on cleaning and disinfection methods for such devices, the amount of premarket data needed to validate cleaning and disinfection and devices and appropriate risk mitigations to prevent infections.

Guidelines and criteria based on risk stratifications schemas will also be discussed, specifically for notifying patients who may have already been exposed to nontuberculous myobacteria infections prior to cardiac surgeries.

Background material will be made available 2 days before the meeting, the FDA said. The meeting is slated to be held June 2 and 3 in D.C.

Last October, the FDA issued a warning over issues with infections associated with heater-cooler devices during cardiothoracic and other surgical procedures.

Heater-cooler devices use water tanks to provide temperature-controlled water to keep patients warm or cool during surgical procedures.

While water in the devices does not contact patients, the federal watchdog warned that there is potential that contaminated water could enter other parts of the device, which could be aerosolized through its exhaust vent.

Exhausted contaminated water could transmit bacteria through the air to the environment and patient, the FDA warned.

The agency warned that the devices have been associated with nontuberculous mycobacteria infections, primarily in patients during cardiothoracic surgical procedures. The data came from analysis of adverse events, medical literature and other public health agencies.

The FDA said it has received 32 medical device reports of patients with infections associated with the devices, with 25 of the reports received during 2015.

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA

More recent news

  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform
  • MiniMed completes split from Medtronic
  • GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy